Floatz logo

Prolastin-C

Chronic Pancreatitis

Medical University of South CarolinaPhase 1/2Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
95/ 100

Competitive context

10 Active assets in the Chronic Pancreatitis cohort.

Asset / SponsorPhaseRating
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
Johns Hopkins University
Phase 3BB
Pancrelipase
Changhai Hospital
Phase 4BB
Triamcinalone
Centre hospitalier de l'Université de Montréal (CHUM)
Phase 3BB
Pregabalin
Asian Institute of Gastroenterology, India
Phase 2/3B
LIDOCAINE
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase 2B

View all 22 →

Same molecule, other indications

Prolastin-C is also rated in:

pulmonary emphysemaDormant
B
Indicative ·
57 / 100
View asset →
alpha 1-antitrypsin deficiencyDormant
NR
Indicative ·
/ 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →